Financials Domesco Medical Import - Export Joint-Stock Corporation

Equities

DMC

VN000000DMC9

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
66,600 VND -0.15% Intraday chart for Domesco Medical Import - Export Joint-Stock Corporation +4.06% +15.83%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,621,924 2,500,377 2,059,339 1,823,192 1,427,299 1,996,829
Enterprise Value (EV) 1 2,275,913 2,141,711 1,826,569 1,512,572 974,595 1,407,268
P/E ratio 11.5 x 10.7 x 11.5 x 11.4 x 7.13 x 12.8 x
Yield 3.31% 3.47% 4.22% 4.76% 6.08% -
Capitalization / Revenue 1.89 x 1.7 x 1.42 x 1.22 x 0.9 x 1.16 x
EV / Revenue 1.64 x 1.46 x 1.26 x 1.01 x 0.61 x 0.82 x
EV / EBITDA 7.76 x 7.25 x 7.98 x 7.19 x 3.84 x 6.96 x
EV / FCF -22.7 x 42.8 x -29.4 x 10.8 x 4 x 10 x
FCF Yield -4.4% 2.34% -3.4% 9.25% 25% 9.97%
Price to Book 2.32 x 2 x 1.57 x 1.33 x 0.98 x 1.31 x
Nbr of stocks (in thousands) 34,727 34,727 34,727 34,727 34,727 34,727
Reference price 2 75,500 72,000 59,300 52,500 41,100 57,500
Announcement Date 3/18/19 3/30/20 3/31/21 4/1/22 4/3/23 4/2/24
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,385,088 1,468,390 1,451,954 1,498,395 1,592,727 1,719,032
EBITDA 1 293,328 295,232 228,776 210,337 253,970 202,211
EBIT 1 263,924 266,947 203,176 186,405 234,484 183,443
Operating Margin 19.05% 18.18% 13.99% 12.44% 14.72% 10.67%
Earnings before Tax (EBT) 1 286,090 290,916 224,566 199,204 250,198 229,175
Net income 1 228,772 232,635 179,535 159,282 200,076 183,333
Net margin 16.52% 15.84% 12.37% 10.63% 12.56% 10.66%
EPS 2 6,588 6,699 5,170 4,587 5,761 4,487
Free Cash Flow 1 -100,216 50,029 -62,098 139,874 243,514 140,283
FCF margin -7.24% 3.41% -4.28% 9.33% 15.29% 8.16%
FCF Conversion (EBITDA) - 16.95% - 66.5% 95.88% 69.37%
FCF Conversion (Net income) - 21.51% - 87.82% 121.71% 76.52%
Dividend per Share 2 2,500 2,500 2,500 2,500 2,500 -
Announcement Date 3/18/19 3/30/20 3/31/21 4/1/22 4/3/23 4/2/24
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 346,011 358,667 232,770 310,620 452,704 589,561
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -100,216 50,029 -62,098 139,874 243,514 140,283
ROE (net income / shareholders' equity) 22% 19.5% 14% 11.9% 14.2% 12.3%
ROA (Net income/ Total Assets) 11.9% 11.1% 8.47% 7.55% 8.47% 6.22%
Assets 1 1,921,256 2,090,214 2,118,659 2,109,470 2,361,725 2,947,946
Book Value Per Share 2 32,526 36,060 37,877 39,336 42,028 43,784
Cash Flow per Share 2 2,289 2,833 3,096 2,458 1,367 3,292
Capex 1 41,930 35,203 14,258 6,114 10,565 7,301
Capex / Sales 3.03% 2.4% 0.98% 0.41% 0.66% 0.42%
Announcement Date 3/18/19 3/30/20 3/31/21 4/1/22 4/3/23 4/2/24
1VND in Million2VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DMC Stock
  4. Financials Domesco Medical Import - Export Joint-Stock Corporation